Targeting aldose reductase using natural African compounds as promising agents for managing diabetic complications
BackgroundDiabetes remains a leading cause of morbidity and mortality due to various complications induced by hyperglycemia. Inhibiting Aldose Reductase (AR), an enzyme that converts glucose to sorbitol, has been studied to prevent long-term diabetic consequences. Unfortunately, drugs targeting AR h...
Saved in:
Main Authors: | Miriam E. L. Gakpey, Shadrack A. Aidoo, Toheeb A. Jumah, George Hanson, Siyabonga Msipa, Florence N. Mbaoji, Omonijo Bukola, Palesa C. Tjale, Mamadou Sangare, Hedia Tebourbi, Olaitan I. Awe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Bioinformatics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbinf.2025.1499255/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The aldose reductase inhibitors AT-001, AT-003 and AT-007 attenuate human keratinocyte senescence
by: Gautham Yepuri, et al.
Published: (2024-12-01) -
Novel Quinoline- and Naphthalene-Incorporated Hydrazineylidene–Propenamide Analogues as Antidiabetic Agents: Design, Synthesis, and Computational Studies
by: Osama Alharbi, et al.
Published: (2024-12-01) -
Natural molecules as promising players against diabetic peripheral neuropathy: an emerging nutraceutical approach
by: Rabia Akram, et al.
Published: (2023-09-01) -
Comparative Modeling and Molecular Dynamics Simulation of Substrate Binding in Human Fatty Acid Synthase: Enoyl Reductase and β-Ketoacyl Reductase Catalytic Domains
by: Arun John, et al.
Published: (2015-03-01) -
Molecular modeling, synthesis and biological evaluation of caffeic acid based Dihydrofolate reductase inhibitors
by: Renu Sehrawat, et al.
Published: (2024-12-01)